Actelion selects IntraLinks to streamline clinical trial info exchange

Tuesday, September 25, 2012 03:06 PM

Actelion Pharmaceuticals, a Switzerland-based biopharmaceutical company that focuses treatments to serve unmet medical needs, has selected IntraLinks, a global technology provider of inter-enterprise content management and collaboration solutions, to streamline their documentation exchange during clinical trials.

“Actelion’s engagement of IntraLinks demonstrates the growing demand for secure information exchange within the clinical trial process,” said Andy Watson, vice president of life sciences EMEA at IntraLinks. “IntraLinks Connect will provide Actelion greater efficiency, traceability, and security to improve communication, collaboration and document exchange between everyone involved in the clinical trial.”

Prior to engaging IntraLinks, Actelion relied on traditional courier services to facilitate the exchange of sensitive clinical trial documentation between sponsors and participants, resulting in excessive shipping costs and manual processes for tracking and other activities.

To streamline their documentation process and gain efficiency for themselves and their investigators, Actelion chose IntraLinks Connect to provide central clinical trial portals to facilitate the more secure, compliant auditable exchange of site feasibility, study start up, study conduct and study close-out documentation.

IntraLinks Connect’s security, detailed reporting, workflows and analytics, together with IntraLinks’ knowledgeable professional service support convinced Actelion that IntraLinks provided the best fit to their requirements.

“Whilst working with IntraLinks we can see the maturity of their technology and the commitment of the team to support Actelion moving forward in this area,” said Christine Schwenninger, head of global clinical monitoring, Actelion. “We are looking forward to working closely together with IntraLinks in the coming years.”

Share:          
CWWeekly

January 26

2015 CRO outlook: M&As, IPOs, strategic partnerships and increased eClinical outsourcing expected to continue

IOM, industry stakeholders propose standards, guidelines for open sharing of clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs